To make the case - Evidence is required

Archives of Internal Medicine

Volumn 171, Issue 17, 2011, Pages 1594-

  Redberg, Rita F ^a   Katz, Mitchell ^a   Grady, Deborah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AMNESIA; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; LIVER DYSFUNCTION; MEDICAL PRACTICE; MYALGIA; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; SURVIVAL; WEAKNESS; CARDIOVASCULAR SYSTEM EXAMINATION; DRUG CONTRAINDICATION; NOTE; CLINICAL TRIAL (TOPIC); LIFE EXTENSION; LIVER FUNCTION; META ANALYSIS (TOPIC); MUSCLE WEAKNESS; RISK; SIDE EFFECT;

DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS;

EID: 80053347468     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.409     Document Type: Editorial

References (1)

1. Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ. 2009;338:b2376.